Michael Metzger Insider Profile

4 Followers
Michael Metzger, President & CEO, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 17.66K shares in Syndax Pharmaceuticals (Ticker: SNDX). Most recently, Michael Metzger ― shares of Tobira Therapeutics on ― for an estimated value of ―.
tipranks
Michael Metzger

Michael Metzger
Tobira Therapeutics (TBRA)
President & CEO, Director

Not Ranked
Michael Metzger has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$404K
100.00%
<0.01%
0.00%
A breakdown of Michael Metzger's holdings

Insider Roles

Syndax Pharmaceuticals
(SNDX)
President & COO, Director
Response Genetics
(RGDXQ)
Director
CTI BioPharma
(CTIC)
Director
Roles that Michael Metzger holds in companies

Most Profitable Insider Trade

Stock:
Response Genetics
(RGDXQ)
Rating:Informative Buy
Date:Feb 06, 2012 - Feb 06, 2013
Return:-22.20%
The most profitable trade made by Michael Metzger

Michael Metzger's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TBRA
Tobira Therapeutics
$0.00
CTI BioPharma
Director
$0.00
Syndax Pharmaceuticals
Nov 06, 2020
President & COO, Director
Uninformative Sell
2.03M
$403.86K
Response Genetics
Feb 06, 2012
Director
Informative Buy
1.50K
$11.00
List of latest transactions for each holding click on a transaction to see Michael Metzger's performance on stock

Michael Metzger insider profile FAQ

What is the percentage of profitable transactions made by Michael Metzger?
The percentage of profitable transactions made by Michael Metzger is ―.
    What is the average return per transaction made by Michael Metzger?
    The average return per transaction made by Michael Metzger is ―.
      What stocks does Michael Metzger hold?
      Michael Metzger holds: TBRA, CTIC, SNDX, RGDXQ stocks.
        What was Michael Metzger’s latest transaction?
        Michael Metzger latest transaction was an Uninformative Buy of ―.
          What was Michael Metzger's most profitable transaction?
          Michael Metzger’s most profitable transaction was an Informative Buy of RGDXQ stock on February 6, 2012. The return on the trade was -22.20%.
            What is Michael Metzger's role in Tobira Therapeutics?
            Michael Metzger's role in Tobira Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.